Finally, our study unexpectedly revealed that HSP27 overexpression sensitized pancreatic cancer cells not only towards gemcitabine but also towards the DR5-targeting agonistic antibodies tigatuzumab and LBY135. This evidence concerns the gene TNFRSF10B and pancreatic neoplasm.